Scientists test re-engineered immune cells to fight deadly brain tumors
NCT ID NCT06946680
Summary
This early-stage study is testing whether modified immune cells can be safely used to treat aggressive brain tumors in children and adults. Researchers are collecting patients' own immune cells, modifying them to target a specific protein found on tumor cells, and then reinfusing them. The main goals are to determine if this approach is safe and feasible, and to find the appropriate dose for future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH GRADE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida Health Children's Hospital
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.